2023

  1. ICD-10-CM Codes
    2. ›
  2. D50-D89
    3. ›
  3. D60-D64
    4. ›
  4. D64-
    5. ›
  5. 2023 ICD-10-CM Diagnosis Code D64

2023 ICD-10-CM Diagnosis Code D64

Other anemias

    2016 2017 2018 2019 2020 2021 2022 2023 Non-Billable/Non-Specific Code
  • D64 should not be used for reimbursement purposes as there are multiple codes below it that contain a greater level of detail.
  • The 2023 edition of ICD-10-CM D64 became effective on October 1, 2022.
  • This is the American ICD-10-CM version of D64 - other international versions of ICD-10 D64 may differ.
Type 1 Excludes
Type 1 Excludes Help
A type 1 excludes note is a pure excludes. It means "not coded here". A type 1 excludes note indicates that the code excluded should never be used at the same time as D64. A type 1 excludes note is for used for when two conditions cannot occur together, such as a congenital form versus an acquired form of the same condition.
  • refractory anemia (
    ICD-10-CM Diagnosis Code D46
    • D46 Myelodysplastic syndromes
      • D46.0 Refractory anemia without ring sideroblasts, ...
      • D46.1 Refractory anemia with ring sideroblasts
      • D46.2 Refractory anemia with excess of blasts [RAEB...
        • D46.20 Refractory anemia with excess of blasts, unsp...
        • D46.21 Refractory anemia with excess of blasts 1
        • D46.22 Refractory anemia with excess of blasts 2
      • D46.A Refractory cytopenia with multilineage dyspla...
      • D46.B Refractory cytopenia with multilineage dyspla...
      • D46.C Myelodysplastic syndrome with isolated del(5q...
      • D46.4 Refractory anemia, unspecified
      • D46.Z Other myelodysplastic syndromes
      • D46.9 Myelodysplastic syndrome, unspecified
    D46.-
    )
  • refractory anemia with excess blasts in transformation [RAEB T] (
    ICD-10-CM Diagnosis Code C92.0

    Acute myeloblastic leukemia

      2016 2017 2018 2019 2020 2021 2022 2023 Non-Billable/Non-Specific Code
    Applicable To
    • Acute myeloblastic leukemia, minimal differentiation
    • Acute myeloblastic leukemia (with maturation)
    • Acute myeloblastic leukemia 1/ETO
    • Acute myeloblastic leukemia M0
    • Acute myeloblastic leukemia M1
    • Acute myeloblastic leukemia M2
    • Acute myeloblastic leukemia with t(8;21)
    • Acute myeloblastic leukemia (without a FAB classification) NOS
    • Refractory anemia with excess blasts in transformation [RAEB T]
    Type 1 Excludes
    • acute exacerbation of chronic myeloid leukemia (C92.10)
    • refractory anemia with excess of blasts not in transformation (D46.2-)
    C92.0-
    )
The following code(s) above D64 contain annotation back-references
Annotation Back-References
In this context, annotation back-references refer to codes that contain:
  • Applicable To annotations, or
  • Code Also annotations, or
  • Code First annotations, or
  • Excludes1 annotations, or
  • Excludes2 annotations, or
  • Includes annotations, or
  • Note annotations, or
  • Use Additional annotations
that may be applicable to D64:
  • D50-D89
    2023 ICD-10-CM Range D50-D89

    Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

    Type 2 Excludes
    • autoimmune disease (systemic) NOS (M35.9)
    • certain conditions originating in the perinatal period (P00-P96)
    • complications of pregnancy, childbirth and the puerperium (O00-O9A)
    • congenital malformations, deformations and chromosomal abnormalities (Q00-Q99)
    • endocrine, nutritional and metabolic diseases (E00-E88)
    • human immunodeficiency virus [HIV] disease (B20)
    • injury, poisoning and certain other consequences of external causes (S00-T88)
    • neoplasms (C00-D49)
    • symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (R00-R94)
    Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
Code History
  • 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
  • 2017 (effective 10/1/2016): No change
  • 2018 (effective 10/1/2017): No change
  • 2019 (effective 10/1/2018): No change
  • 2020 (effective 10/1/2019): No change
  • 2021 (effective 10/1/2020): No change
  • 2022 (effective 10/1/2021): No change
  • 2023 (effective 10/1/2022): No change
ICD-10-CM Codes Adjacent To D64
D61.811 Other drug-induced pancytopenia
D61.818 Other pancytopenia
D61.82 Myelophthisis
D61.89 Other specified aplastic anemias and other bone marrow failure syndromes
D61.9 Aplastic anemia, unspecified
D62 Acute posthemorrhagic anemia
D63 Anemia in chronic diseases classified elsewhere
D63.0 Anemia in neoplastic disease
D63.1 Anemia in chronic kidney disease
D63.8 Anemia in other chronic diseases classified elsewhere
D64 Other anemias
D64.0 Hereditary sideroblastic anemia
D64.1 Secondary sideroblastic anemia due to disease
D64.2 Secondary sideroblastic anemia due to drugs and toxins
D64.3 Other sideroblastic anemias
D64.4 Congenital dyserythropoietic anemia
D64.8 Other specified anemias
D64.81 Anemia due to antineoplastic chemotherapy
D64.89 Other specified anemias
D64.9 Anemia, unspecified
D65 Disseminated intravascular coagulation [defibrination syndrome]

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Advertise with Us | License ICD10 Data

Copyright © | ICD10data.com